PLANTVAX, INC.

Basic Information

9430 Key West Ave
SUITE 120
ROCKVILLE, MD, 20850-

Company Profile

n/a

Additional Details

Field Value
DUNS: 801465928
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: n/a


  1. Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm

    Amount: $1,612,337.00

    DESCRIPTION (provided by applicant): Organophosphorus (OPs) compound are potent neurotoxic chemicals that are widely used in medicine, industry and agriculture; most notably as insecticides. The neur ...

    SBIR Phase II 2013 Department of Health and Human Services
  2. Passive immunotherapy using plant-derived broadly HIV-1 neutralizing MAbs to prev

    Amount: $1,496,976.00

    DESCRIPTION (provided by applicant): In the absence of specific intervention and with extended breast-feeding mother-to- child-transmission of HIV reaches a rate of ~35 % and infection of ~700,000 bab ...

    SBIR Phase II 2011 Department of Health and Human Services
  3. Aerosol Delivery of a Recombinant Butyrylcholinesterase BioShield to Protect Ag

    Amount: $545,727.00

    DESCRIPTION (provided by applicant): Organophosphorus (OPs) compound are potent neurotoxic chemicals that are widely used in medicine, industry and agriculture; most notably as insecticides. The neuro ...

    SBIR Phase II 2010 Department of Health and Human Services
  4. Aerosol Delivery of a Recombinant Butyrylcholinesterase BioShield to Protect Ag

    Amount: $1,451,767.00

    DESCRIPTION (provided by applicant): Organophosphorus (OPs) compound are potent neurotoxic chemicals that are widely used in medicine, industry and agriculture; most notably as insecticides. The neuro ...

    SBIR Phase I 2009 Department of Health and Human Services
  5. Passive immunotherapy using plant-derived broadly HIV-1 neutralizing MAbs to prev

    Amount: $256,501.00

    DESCRIPTION (provided by applicant): While many HIV vaccine regimens have elicited robust viral-specific T cell responses, they have been unable to prevent infection. To date, passive immunotherapy wi ...

    SBIR Phase I 2009 Department of Health and Human Services
  6. A Plant-Derived Recombinant Bioscavenger to Prevent Insecticide Neurotoxicity

    Amount: $169,584.00

    DESCRIPTION (provided by applicant): P.I. Rosenberg, Y.J. ABSTRACT Organophosphorus (OPs) compound are potent neurotoxic chemicals that are widely used in medicine, industry and agriculture; most nota ...

    SBIR Phase I 2007 Department of Health and Human Services
  7. Induction of 2G12 neutralizing antibody by plant-derived HIVgp145

    Amount: $222,753.00

    DESCRIPTION (provided by applicant): HIV infections and vaccines have historically been disappointingly poor at eliciting antibodies that neutralize primary isolates, thus the identification of a hig ...

    SBIR Phase I 2007 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government